MarketPulse

single-dose treatment

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Dndi And Sanofi

CHMP Endorses Single-Dose Acoziborole for Gambian Sleeping Sickness

CHMP endorses single-dose acoziborole for sleeping sickness, showing 96% efficacy. Sanofi and DNDi developed the treatment, which will be donated to WHO.
SNYacoziborole Winthropsleeping sickness
GlobeNewswire Inc.GlobeNewswire Inc.··Dndi And Sanofi

DNDi-Sanofi sleeping sickness drug wins EMA backing as simplified single-dose option

EMA approves DNDi-Sanofi's Acoziborole Winthrop, a simplified single-dose sleeping sickness treatment with 96% efficacy. Sanofi will donate it to WHO for endemic countries.
SNYsleeping sicknessCHMP approval